AtaiBeckley
ATAI
7.35
0.00
0.00%
AtaiBeckley
US · ATAI
#2575 by market cap
Listed 2021
7.35
0.00
0.00%
Live - 5344 symbols - heartbeat 516s ago
· 2026-10-07 19:54
- Market cap
- 2.73B
- P/E (TTM)i
- -2.63
- P/Bi
- 15.44
- EPSi
- -2.91
- Div yieldi
- 0.00%
- 52W posi
- 98%
Reader sentiment
Are you bullish or bearish on ATAI?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Company notice
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Apeiron Investment Group Ltd.SEC · 2025/3/25
-
H.C. Wainwright Maintains AtaiBeckley(ATAI.US) With Hold Rating, Maintains Target Price $7.5Market Newswire · 2026/8/21
-
U.S. Stocks Move Sharply | Atai Life Sciences plc (ATAI.US) Surges Over 30% at Open Following Eli Lilly and Co's Acquisition Offer of Up to $3.8 BillionZhitong Finance · 2026/7/16
-
Deutsche Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $8Market Newswire · 2026/8/12
-
Rating change
H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5Market Newswire · 2026/7/20
-
Rating change
A Quick Look at Today's Ratings for AtaiBeckley(ATAI.US), With a Forecast Between $7.5 to $8Market Newswire · 2026/7/17
-
Company notice
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Apeiron Investment Group Ltd.SEC · 2025/10/3
-
Company notice
ATAI Life Sciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Apeiron Investment Group Ltd.SEC · 2025/8/19
-
Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)TipRanks · 2026/8/20
-
Rating change
Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)TipRanks · 2026/7/18
-
Company notice
AtaiBeckley: AtaiBeckley Inc. - Anticipated Cash Settlement Option Symbol: ATAIOCC · 2026/8/12
-
Company notice
AtaiBeckley: AtaiBeckley Inc. - Cash Settlement/Acceleration of Expirations Option Symbol: ATAIOCC · 2026/9/11
-
Rating change
Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)TipRanks · 2026/8/12
-
Rating change
Maxim Group Maintains AtaiBeckley(ATAI.US) With Hold RatingMarket Newswire · 2026/7/18
-
Rating change
Berenberg Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.45Market Newswire · 2026/7/20
-
Rating change
Berenberg Bank Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2026/7/18
-
Rating change
Oppenheimer Downgrades AtaiBeckley(ATAI.US) to Hold RatingMarket Newswire · 2026/8/18
-
Rating change
TD Cowen Downgrades AtaiBeckley(ATAI.US) to Hold RatingMarket Newswire · 2026/7/18
-
Rating change
Jefferies Maintains AtaiBeckley(ATAI.US) With Hold Rating, Maintains Target Price $7.5Market Newswire · 2026/7/17
-
News On AtaiBeckley Inc. (ATAI) Now Under LLYDow Jones · 2026/9/12
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.